Amdocs Ltd. Stock Plummets to New 52-Week Low of $59.42

Amdocs has reached a new 52-week low, trading at USD 59.42 as of May 13, 2026. This marks a significant decline for the small-cap company, which operates in the Computers - Software & Consulting industry. Over the past year, Amdocs has experienced a performance drop of 22.58%, contrasting sharply with the S&P 500's gain of 26.46%. The company's market capitalization stands at USD 17,662 million, with a price-to-earnings (P/E) ratio of 28.00. Amdocs maintains a low debt-to-equity ratio of 0.17, indicating a conservative approach to leverage. The return on equity (ROE) is reported at 18.45%, reflecting effective management efficiency. However, the company has faced challenges in long-term growth, with net sales increasing at an annual rate of only 1.68% and operating profit at 7.31% over the last five years. Despite these metrics, Amdocs has shown a consistent underperformance against the S&P 500 over the past three years, with a notable return of -30.10% in the last year. The stock's price-to-book ratio is 5.16, suggesting it is trading at a premium compared to historical valuations within its sector.